IACCARINO, Guido
 Distribuzione geografica
Continente #
NA - Nord America 13.717
AS - Asia 10.981
EU - Europa 3.286
SA - Sud America 760
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 5
Totale 28.890
Nazione #
US - Stati Uniti d'America 13.601
HK - Hong Kong 6.483
SG - Singapore 1.994
CN - Cina 927
IT - Italia 751
VN - Vietnam 719
UA - Ucraina 708
BR - Brasile 605
DE - Germania 385
RU - Federazione Russa 385
TR - Turchia 245
IE - Irlanda 230
FR - Francia 205
FI - Finlandia 183
KR - Corea 181
SE - Svezia 178
IN - India 102
GB - Regno Unito 90
AR - Argentina 58
BD - Bangladesh 55
MX - Messico 46
CA - Canada 43
JP - Giappone 41
PL - Polonia 35
IQ - Iraq 33
NL - Olanda 33
ZA - Sudafrica 33
ES - Italia 28
PK - Pakistan 27
EC - Ecuador 24
ID - Indonesia 23
EU - Europa 20
VE - Venezuela 20
UZ - Uzbekistan 19
PH - Filippine 17
AT - Austria 16
MY - Malesia 16
SA - Arabia Saudita 16
JO - Giordania 15
KE - Kenya 14
PY - Paraguay 14
TN - Tunisia 14
CL - Cile 12
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
CZ - Repubblica Ceca 10
CO - Colombia 9
MA - Marocco 9
EG - Egitto 7
JM - Giamaica 7
AL - Albania 6
BO - Bolivia 6
IL - Israele 6
KZ - Kazakistan 6
NP - Nepal 6
PE - Perù 6
BH - Bahrain 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
KG - Kirghizistan 5
LT - Lituania 5
AO - Angola 4
BE - Belgio 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
GR - Grecia 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
AU - Australia 3
BG - Bulgaria 3
GE - Georgia 3
GH - Ghana 3
LU - Lussemburgo 3
MK - Macedonia 3
OM - Oman 3
BB - Barbados 2
GY - Guiana 2
HN - Honduras 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
NO - Norvegia 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
YT - Mayotte 2
AM - Armenia 1
BJ - Benin 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
Totale 28.868
Città #
Hong Kong 6.471
Ann Arbor 2.883
Wilmington 2.393
Singapore 1.056
Jacksonville 883
Woodbridge 854
Chandler 846
San Jose 830
Princeton 691
Houston 575
Dallas 447
Ashburn 417
Dong Ket 307
Dublin 229
Council Bluffs 219
The Dalles 209
Izmir 205
Lauterbourg 185
Nanjing 159
Andover 158
Boardman 158
Beijing 149
Pellezzano 138
Ho Chi Minh City 136
Mestre 135
Moscow 124
Los Angeles 100
Dearborn 97
Hanoi 89
Munich 88
Salerno 86
Düsseldorf 80
Fairfield 71
New York 68
São Paulo 59
Changsha 56
Shenyang 53
Hebei 44
Falls Church 42
Nanchang 42
Tokyo 40
Santa Clara 37
Orem 33
Jiaxing 32
Saint Petersburg 32
Milan 31
Napoli 31
Norwalk 31
Warsaw 30
Rome 28
San Francisco 26
Turku 25
Montreal 24
Tianjin 24
Rio de Janeiro 23
Venezia 23
Johannesburg 22
London 22
San Diego 22
Brooklyn 21
Nuremberg 20
Denver 19
Frankfurt am Main 19
Jinan 18
Manchester 18
Chennai 17
Grevenbroich 17
Naples 17
Phoenix 17
Redwood City 17
Stockholm 17
Tashkent 17
Atlanta 16
Columbus 16
Da Nang 16
Haiphong 16
Mexico City 16
Cambridge 15
Guangzhou 15
Pune 15
Washington 15
Poplar 13
Seattle 13
Shanghai 13
Amman 12
Amsterdam 12
Baghdad 12
Biên Hòa 12
Charlotte 12
Nairobi 12
Seoul 12
Curitiba 11
Helsinki 11
Lappeenranta 11
Mumbai 11
New Delhi 11
Ninh Bình 11
Belo Horizonte 10
Boston 10
Dhaka 10
Totale 22.961
Nome #
Difficult-to-control hypertension: identification of clinical predictors and use of ICT-based integrated care to facilitate blood pressure control 881
Serum uric acid predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 858
Physical activity ameliorates cardiovascular health in elderly subjects: the functional role of the Beta adrenergic system. 564
G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. 514
Insulin-induced changes in beta-adrenergic response: an experimental study in the isolated rat papillary muscle. 497
"Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors 432
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 425
Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. 306
The Italian version of the quick mild cognitive impairment (Qmci-I) screen: normative study on 307 healthy subjects 299
Mitochondrial Localization Unveils a Novel Role for Grk2 in the Regulation of Oxidative Metabolism 291
SAR study and conformational analysis of a series of novel peptide G protein-coupled receptor kinase 2 inhibitors 291
Adrenergic signaling in heart failure and cardiovascular aging 283
Integrated care pathways for airway diseases (AIRWAYS-ICPs) 277
G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. 273
Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. 254
Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene. 249
Serum uric acid and left ventricular mass in essential hypertension 246
The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. 243
Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. 240
Thyroid function predicts increased cardiovascular risk 234
Characterization of a selective CaMKII peptide inhibitor 215
Vitamin D, parathyroid hormone and cardiovascular risk: The good, the bad and the ugly 215
Enhanced GRK2 expression and desensitization of betaAR vasodilatation in hypertensive patients. 210
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque 207
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy 203
To NFκB or not to NFκB: The Dilemma on How to Inhibit a Cancer Cell Fate Regulator 203
A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. 202
Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs. 201
A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells 195
Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice 190
L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. 190
AKT participates in endothelial dysfunction in hypertension. 189
Influence of digitalis on left ventricular functional response to exercise in congestive heart failure. 185
Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension. 183
Age-Related Impairment in Insulin Release: The Essential Role of β2-Adrenergic Receptor. 182
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. 177
Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. 176
A Novel CaMKII/ERK Interaction n the Heart Sustains Cardiac Hypertrophy in Spontaneously Hypertensive Rats 172
Targeting myocardial remodelling to develop novel therapies for heart failure 172
G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. 165
Cardiotoxic effects of short-term doxorubicin administration: Involvement of connexin 43 in calcium impairment 165
Mitochondrial localization unveils a novel role for GRK2 in organelle biogenesis 164
Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. 163
Acute noradrenergic activation induces insulin resistance in human skeletal muscle 157
Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. 157
Mitochondrial G protein coupled receptor kinase 2 regulates proinflammatory responses in macrophages. 157
Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20-21, 2014, Lisbon July 2, 2015 156
Active and Healthy Ageing and Independent Living 2016 154
Active and Healthy Ageing and Independent Living 154
Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy. 153
A novel CaMKII/ERK interaction in the heart sustains cardiac hypertrophy in spontaneously hypertensive rats 153
Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity 152
The Glu27 allele of the beta2 adrenergic receptor increases the risk of cardiac hypertrophy in hypertension. 151
Transgenic mice targeting the heart unveil G protein-coupled receptor kinases as therapeutic targets. 151
G beta gamma-mediated signaling: new therapeutic target for proliferative vascular disease. 150
Association Study on Long-Living Individuals from Southern Italy Identifies rs10491334 in the CAMKIV Gene That Regulates Survival Proteins. 149
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 148
β2-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis 146
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling. 146
The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis 145
A POLYMORPHISM WITHIN THE PROMOTER OF THE DOPAMINE RECEPTOR D1 (DRD1-48A/G) ASSOCIATES WITH IMPAIRED KIDNEY FUNCTION IN WHITE HYPERTENSIVE PATIENTS 145
Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm. 145
Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. 144
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors 144
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 142
ADRENERGIC MECHANISM IN THE CONTROL OF ENDOTHELIAL FUNCTION 141
Endothelial g protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. 141
Redesigning service delivery for hypertensive patients: a methodological guideline to improve the management of chronic diseases 141
Prior exercise improves age-dependent vascular endothelial growth factor downregulation and angiogenesis responses to hind-limb ischemia in old rats 140
The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. 140
[Non-hemodynamic mechanisms of cardiovascular risk in the hypertensive patient: insulin resistance]. 138
Insulin reduces reflex forearm sympathetic vasoconstriction in healthy humans. 138
GRK2 endothelial deletion causes hypotension and defective vasoconstriction in Tie2-CRE/GRK2fl/fl transgenic mice 136
CaMK4 Gene Deletion Induces Hypertension 135
Myocardial G protein-coupled receptor kinases: implications for heart failure therapy. 133
Microwave-Assisted Synthesis of KN-93, a Potent and Selective Inhibitor of Ca2+/Calmoduline-Dependent Protein Kinase II 133
G Protein-Coupled Receptor Kinases and Hypertension 133
The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. 133
Good at Heart: Preserving Cardiac Metabolism during aging 132
ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models. 131
Insufficient control of blood pressure and incident diabetes. 131
External support modulates G protein expression and receptor coupling in experimental vein grafts. 131
New Insights in Cardiac Calcium Handling and Excitation-Contraction Coupling 131
P501 * GRK2 inhibition with small peptide improves cardiac function during heart failure 130
Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. 130
The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension. 129
Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. 128
Trafficking GRK2: Cellular and Metabolic consequences of GRK2 subcellular localization 128
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 128
Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. 127
Atrial fibrillation and microRNAs 127
The mechanisms of air pollution and particulate matter in cardiovascular diseases 126
Insulin modulation of beta-adrenergic vasodilator pathway in human forearm. 125
Enhanced Expression of ss3-Adrenoceptors in Cardiac Myocytes Attenuates Neurohormone-Induced Hypertrophic Remodeling through Nitric Oxide Synthase. 125
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes 125
Operational definition of Active and Healthy Ageing (AHA): A conceptual framework 125
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 124
The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. 124
CaMKII protects MKP-1 from proteasome degradation in endothelial cells. 124
Adenoviral-mediated inhibition of Gβγ signaling limits the hyperplastic response in experimental vein grafts 121
Totale 19.864
Categoria #
all - tutte 84.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021498 0 0 0 0 0 0 0 0 0 5 148 345
2021/20221.236 3 0 5 11 62 45 16 60 183 167 150 534
2022/20231.960 209 124 28 231 282 415 8 207 312 2 101 41
2023/2024728 99 105 33 36 42 67 26 44 13 55 26 182
2024/20252.001 82 28 18 68 91 310 248 214 330 131 235 246
2025/202612.553 1.316 3.436 2.799 475 955 551 1.471 316 505 729 0 0
Totale 29.335